Only show
results from:

Sort results by:

Display preferences
43,860 results sorted by relevancy Results per page:
ACCESS PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 1996 RESULTS.
Business Wire; May 16, 1996; 700+ Words ...Pharmaceuticals, Inc. ("ACCESS" or the "Company...offers a balance to ACCESS' existing portfolio...public company. ACCESS Pharmaceuticals is an emerging pharmaceutical company with a...carriers. ACCESS PHARMACEUTICALS, INC. a development...
Access Pharmaceuticals, Inc. Signs Amlexanox Licensing Agreement With Zambon Group.
PR Newswire; Jan 14, 2003; 700+ Words ACCESS PHARMACEUTICALS, INC. today announced...highly successful pharmaceutical company with a rapidly...is a multinational pharmaceutical company with an international...dermatology. Access Pharmaceuticals, Inc. is an emerging...
Access Pharmaceuticals, Inc. Announces Signing of Agreement for Canada for Marketing Rights for Amlexanox.
Business Wire; Aug 20, 1998; 700+ Words ...Aug. 20, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS...with Paladin Labs, Inc. ("Paladin") to...distribution of innovative pharmaceuticals for the Canadian market...ranks in the top 20 pharmaceutical companies in Canada...Access Pharmaceuticals, Inc. is a ...
Access Pharmaceuticals, Inc. Announces FDA Approval of OraDisc(TM) A.
PR Newswire; Sep 30, 2004; 700+ Words ACCESS PHARMACEUTICALS, INC. announced today the receipt...strategic partners." Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...of Access Pharmaceuticals, Inc., +1-214-905-5100...
Access Pharmaceuticals, Inc. Announces Agreement With Block Drug Company for the International Rights to Amlexanox.
Business Wire; Jun 4, 1998; 700+ Words ...June 4, 1998--Access Pharmaceuticals, Inc. (OTC/BULLETIN BOARD...Access Pharmaceuticals, Inc. and Block Drug Company...president and CEO of Access Pharmaceuticals, stated, "Access...profitable emerging pharmaceutical company." Access ...
Access Pharmaceuticals, Inc. Provides OraDisc(TM) Technology Update.
PR Newswire; Oct 8, 2004; 700+ Words ACCESS PHARMACEUTICALS, INC. today provided an update on the OraDisc(TM...opportunities for the OraDisc(TM) technology." Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing both novel low development...
Other News To Note.(Access Pharmaceuticals Inc. stock reports)(Acumen Pharmaceutical Inc. gets research grants)(Advanced Magnetics Inc. goes for new drug filing for ferumoxytol)
BIOWORLD Today; Aug 12, 2005; 700+ Words Access Pharmaceuticals Inc., of Dallas, saw its stock...Thursday, down 49 cents. Acumen Pharmaceutical Inc., of South San Francisco, said...to close at $10.40. Anadys Pharmaceuticals Inc., of San Diego, closed...
Access Pharmaceuticals, Inc. Announces Publication in 'Nature'.
Business Wire; Aug 5, 1998; 700+ Words ...HealthWire)--Aug. 5, 1998--ACCESS PHARMACEUTICALS, INC. (OTC BB:AXCS) today announced...shortly. Access Pharmaceuticals, Inc. is a site-directed targeting...CONTACT: Access Pharmaceuticals, Inc. Kerry P. Gray, 214/905...
Access Pharmaceuticals, Inc. Announces Board Appointment.
PR Newswire; Dec 11, 2002; 700+ Words ACCESS PHARMACEUTICALS, INC. today announced the appointment...position of 14.2%. Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...of Access Pharmaceuticals, Inc., +1-214-905-5100...
Access Pharmaceuticals, Inc. Announces Filing of AP5346 IND With the FDA.
PR Newswire; Dec 22, 2004; 700+ Words ACCESS PHARMACEUTICALS, INC. announced today that it has filed an Investigational...oxaliplatin in inhibiting the growth of tumors. Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing both novel low development...
OTHER NEWS TO NOTE.(Access Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., Genetech Inc., Biogen Idec Inc.)
BIOWORLD Today; Aug 18, 2005; 700+ Words Access Pharmaceuticals Inc., of Dallas, said it implemented plans...at 97 cents. Alexion Pharmaceuticals Inc., of Cheshire, Conn., completed...marketed product. Ceragenix Pharmaceuticals Inc., of Denver, said its chief scientific...
Access Pharmaceuticals, Inc., Announces Zindaclin(R) Receives Approval In Eight Additional European Markets.
PR Newswire; Dec 19, 2002; 700+ Words ...License Agreements Executed ACCESS PHARMACEUTICALS, INC. today announced that...revenue stream." Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...Access Pharmaceuticals, Inc., +1-214-905...
Access Pharmaceuticals, Inc. to Conduct Conference Call.
PR Newswire; Jan 14, 2003; 674 Words ...Today's Announcements - ACCESS PHARMACEUTICALS, INC. today announced that...21108669). Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...Access Pharmaceuticals, Inc., +1-214-905...
Access Pharmaceuticals, Inc. Announces Conference Call for Third Quarter Financial Results.
PR Newswire; Nov 11, 2002; 700+ Words ACCESS PHARMACEUTICALS, INC. today announced that it...confirmation # 21027874). Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...of Access Pharmaceuticals, Inc., +1-214-905-5100...
Access Pharmaceuticals, Inc. Announces Conference Call to Discuss the 2004 Third Quarter Financial Results.
PR Newswire; Nov 15, 2004; 700+ Words ACCESS PHARMACEUTICALS, INC. today announced that it...Access code #756364). Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...for Access Pharmaceuticals, Inc.; or Kerry P. Gray, President...
Access Pharmaceuticals, Inc. Announces Conference Call to Discuss Recent Developments.
PR Newswire; Oct 4, 2004; 700+ Words ACCESS PHARMACEUTICALS, INC. today announced that it...Access code #749820). Access Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on developing...for Access Pharmaceuticals, Inc.; or Kerry P. Gray, President...
While Access Pharmaceuticals, Inc. Conducts a Conference Call, Others Announce Financial Results, Report Drill Results, Announce Accomplishments, Net Income, and Partner Up.
M2 Presswire; Feb 22, 2007; 700+ Words ...com: While Access Pharmaceuticals, Inc. Conducts...232644). The access number for...Access Pharmaceuticals, Inc. engages in...technology. Access Pharmaceuticals was founded...Communicate.com Inc. (OTCBB CMNN...
Access Pharmaceuticals, Inc. Announces Filing of Product License Application in the UK and Execution of License Agreement.
Business Wire; Aug 18, 1998; 700+ Words ...Healthwire)--Aug. 18, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS) today announced...indications. Access Pharmaceuticals, Inc. is a site-directed drug targeting...CONTACT: Access Pharmaceuticals, Inc., Dallas Kerry P. Gray, 214...
Access Pharmaceuticals Inc. Agrees to License Amlexanox for Eight European Countries.
Business Wire; Oct 2, 1998; 700+ Words ...Healthwire)--Oct. 2, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS) today announced...CEO of Access Pharmaceuticals, Inc. stated, "Meda AB has a strong...1999. Access Pharmaceuticals, Inc. is a site-directed drug targeting...
Access Pharmaceuticals, Inc. Agrees to License Amlexanox for Four Additional European Markets.
Business Wire; Oct 15, 1998; 700+ Words ...Oct. 15, 1998--Access Pharmaceuticals, Inc. (OTC BB:AXCS...and CEO of Access Pharmaceuticals, Inc., stated "Laboratorios...the third largest pharmaceutical company in Spain...Pharmaceuticals, Inc. is a site-directed...
43,860 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives